• AAPL 165
  • TSLA 147.05
  • AMZN 174.63
  • MSFT 399.12
  • INTC 34.2
  • EURUSD 1.0661
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. TBBA.PINK

Teb Bancorp Inc (TBBA PINK) stock market data APIs

$6.3 -0.09(-1.4%) as of April 19, 2024

Teb Bancorp Inc Financial Data Overview

6.3875
6.3
-
6.3875
6.3
5.254-9.5
16 763 K
5.2789
2 624 K
11 894 K
-0.1945
0.317
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TBBA',
Type: 'Common Stock',
Name: 'Teb Bancorp Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00MJ4TD75',
ISIN: NULL,
CUSIP: NULL,
CIK: '1751700',
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Financial Services',
Industry: 'Banks - Regional',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Teb Bancorp Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 11 894 K
  • EBITDA 0
  • Earnings Per Share 1.21
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Teb Bancorp Inc Earnings via APIs

  • Latest Release 2024-01-30
  • EPS/Forecast NaN

Get Teb Bancorp Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Teb Bancorp Inc latest news via APIs

Marinus Enrolls First Patient in Pivotal Phase 3 Clinical Trial of IV Ganaxolone in Refractory Status Epilepticus

Marinus and Ceribell, Inc. agree to place handheld Ceribell Rapid Response EEG systems in hospitals in connection with its Phase 3 RSE clinical trial Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a p...
  • BENZODIAZEPINES
  • CLINICAL TRIAL
  • EEG
  • GANAXOLONE
  • INC
  • MARINUS
  • MARINUS PHARMACEUTICALS
  • RAPID RESPONSE
  • RSE
  • STATUS EPILEPTICUS

Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of Ganaxolone in CDKL5 Deficiency Disorder (CDD)

Marinus is moving towards a pre-NDA meeting, targeted for the end of Q1, in support of NDA submission by the end of Q2 Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated...
  • CDD
  • CLINICAL TRIAL
  • CLINICAL TRIALS
  • FOOD AND DRUG ADMINISTRATION
  • GANAXOLONE
  • INC
  • MARINUS
  • MARINUS PHARMACEUTICALS
  • NDA SUBMISSION
  • PHASE 3 TRIAL
Do you have any questions?
support@eodhistoricaldata.com